Combined treatment with interferon (IFN)-γ and tumor necrosis factor (TNF)-α up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 117 (2) , 303-311
- https://doi.org/10.1016/0008-8749(88)90120-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Differential expression of hla antigen of HLA anigens on human B-cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells?International Journal of Cancer, 1988
- Absence, or low expression, of leukocyte adhesion molecules CDI1 and CD18 on burkjtt lymphoma cellsInternational Journal of Cancer, 1988
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.The Journal of Experimental Medicine, 1985
- Induction of the expression of HLA class I antigens on K562 by interferons and sodium butyrateHuman Immunology, 1985
- THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANSTransplantation, 1984
- Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunityNature, 1983
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Establishment in continuous culture of a new type of lymphocyte from a “burkitt‐like” malignant lymphoma (line d.g.‐75)International Journal of Cancer, 1977